

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 6.05389087 |
| 2 | negative regulation of fibrinolysis (GO:0051918) | 5.73290585 |
| 3 | Notch signaling involved in heart development (GO:0061314) | 5.55695376 |
| 4 | patterning of blood vessels (GO:0001569) | 5.33396744 |
| 5 | * lymph vessel development (GO:0001945) | 5.29540925 |
| 6 | positive regulation of endothelial cell differentiation (GO:0045603) | 5.25541328 |
| 7 | ventricular trabecula myocardium morphogenesis (GO:0003222) | 5.14642362 |
| 8 | endothelium development (GO:0003158) | 5.06413786 |
| 9 | angiogenesis involved in wound healing (GO:0060055) | 4.97713829 |
| 10 | regulation of fibrinolysis (GO:0051917) | 4.97291596 |
| 11 | transcytosis (GO:0045056) | 4.91256413 |
| 12 | * vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 4.91232408 |
| 13 | L-phenylalanine catabolic process (GO:0006559) | 4.76874239 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.76874239 |
| 15 | L-phenylalanine metabolic process (GO:0006558) | 4.61088643 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.61088643 |
| 17 | * vascular endothelial growth factor signaling pathway (GO:0038084) | 4.59302730 |
| 18 | embryonic heart tube development (GO:0035050) | 4.57922628 |
| 19 | heart trabecula morphogenesis (GO:0061384) | 4.57268125 |
| 20 | interleukin-6-mediated signaling pathway (GO:0070102) | 4.56022021 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.47681860 |
| 22 | protein carboxylation (GO:0018214) | 4.47681860 |
| 23 | regulation of blood vessel endothelial cell migration (GO:0043535) | 4.45811643 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.44995398 |
| 25 | glomerular filtration (GO:0003094) | 4.39516625 |
| 26 | trabecula morphogenesis (GO:0061383) | 4.38813835 |
| 27 | blood vessel endothelial cell migration (GO:0043534) | 4.32471109 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.31421096 |
| 29 | * cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.29836434 |
| 30 | * lymphangiogenesis (GO:0001946) | 4.25984269 |
| 31 | alpha-linolenic acid metabolic process (GO:0036109) | 4.23064452 |
| 32 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 4.22252753 |
| 33 | regulation of protein activation cascade (GO:2000257) | 4.15047099 |
| 34 | aromatic amino acid family catabolic process (GO:0009074) | 4.13880631 |
| 35 | * sprouting angiogenesis (GO:0002040) | 4.13045541 |
| 36 | vasculogenesis (GO:0001570) | 4.08455938 |
| 37 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 4.06414789 |
| 38 | reverse cholesterol transport (GO:0043691) | 4.05597406 |
| 39 | regulation of complement activation (GO:0030449) | 3.95901832 |
| 40 | Notch receptor processing (GO:0007220) | 3.95300101 |
| 41 | glyoxylate metabolic process (GO:0046487) | 3.94663155 |
| 42 | renal filtration (GO:0097205) | 3.94397956 |
| 43 | positive regulation of vasculogenesis (GO:2001214) | 3.93538270 |
| 44 | sexual reproduction (GO:0019953) | 3.89241119 |
| 45 | kynurenine metabolic process (GO:0070189) | 3.86553875 |
| 46 | negative regulation of epithelial cell migration (GO:0010633) | 3.85460153 |
| 47 | estrogen biosynthetic process (GO:0006703) | 3.83966955 |
| 48 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.82133123 |
| 49 | bile acid biosynthetic process (GO:0006699) | 3.81095989 |
| 50 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.77858203 |
| 51 | coronary vasculature morphogenesis (GO:0060977) | 3.77631744 |
| 52 | surfactant homeostasis (GO:0043129) | 3.77621751 |
| 53 | cell migration involved in sprouting angiogenesis (GO:0002042) | 3.76354978 |
| 54 | heart valve formation (GO:0003188) | 3.75223148 |
| 55 | acylglycerol homeostasis (GO:0055090) | 3.70418662 |
| 56 | triglyceride homeostasis (GO:0070328) | 3.70418662 |
| 57 | semaphorin-plexin signaling pathway (GO:0071526) | 3.69459493 |
| 58 | phospholipid homeostasis (GO:0055091) | 3.69003356 |
| 59 | complement activation, alternative pathway (GO:0006957) | 3.66187713 |
| 60 | drug catabolic process (GO:0042737) | 3.66185079 |
| 61 | blood vessel remodeling (GO:0001974) | 3.60894009 |
| 62 | tryptophan catabolic process (GO:0006569) | 3.60832501 |
| 63 | indole-containing compound catabolic process (GO:0042436) | 3.60832501 |
| 64 | indolalkylamine catabolic process (GO:0046218) | 3.60832501 |
| 65 | morphogenesis of an endothelium (GO:0003159) | 3.59546048 |
| 66 | endothelial tube morphogenesis (GO:0061154) | 3.59546048 |
| 67 | artery development (GO:0060840) | 3.57845740 |
| 68 | negative regulation of angiogenesis (GO:0016525) | 3.55794243 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 3.55494844 |
| 70 | macromolecular complex remodeling (GO:0034367) | 3.55494844 |
| 71 | plasma lipoprotein particle remodeling (GO:0034369) | 3.55494844 |
| 72 | blood coagulation, intrinsic pathway (GO:0007597) | 3.53799626 |
| 73 | negative regulation of blood coagulation (GO:0030195) | 3.53664887 |
| 74 | negative regulation of hemostasis (GO:1900047) | 3.53664887 |
| 75 | basement membrane organization (GO:0071711) | 3.53652164 |
| 76 | exogenous drug catabolic process (GO:0042738) | 3.53416530 |
| 77 | nephron epithelium development (GO:0072009) | 3.53296983 |
| 78 | chemical homeostasis within a tissue (GO:0048875) | 3.52890513 |
| 79 | fibrinolysis (GO:0042730) | 3.52119340 |
| 80 | lysine metabolic process (GO:0006553) | 3.51328037 |
| 81 | lysine catabolic process (GO:0006554) | 3.51328037 |
| 82 | labyrinthine layer development (GO:0060711) | 3.49987195 |
| 83 | positive regulation of blood coagulation (GO:0030194) | 3.49134322 |
| 84 | positive regulation of hemostasis (GO:1900048) | 3.49134322 |
| 85 | aorta morphogenesis (GO:0035909) | 3.48440889 |
| 86 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.48107564 |
| 87 | plasma lipoprotein particle clearance (GO:0034381) | 3.47062105 |
| 88 | sulfur amino acid catabolic process (GO:0000098) | 3.46830181 |
| 89 | tryptophan metabolic process (GO:0006568) | 3.45483316 |
| 90 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.44781904 |
| 91 | regulation of synapse maturation (GO:0090128) | 3.42424350 |
| 92 | * regulation of endothelial cell migration (GO:0010594) | 3.42303579 |
| 93 | regulation of endothelial cell differentiation (GO:0045601) | 3.42296786 |
| 94 | negative regulation of blood vessel morphogenesis (GO:2000181) | 3.39430277 |
| 95 | regulation of triglyceride catabolic process (GO:0010896) | 3.39103472 |
| 96 | urea metabolic process (GO:0019627) | 3.38986316 |
| 97 | urea cycle (GO:0000050) | 3.38986316 |
| 98 | cAMP biosynthetic process (GO:0006171) | 3.37869911 |
| 99 | potassium ion import (GO:0010107) | 3.35543629 |
| 100 | protein activation cascade (GO:0072376) | 3.34235054 |
| 101 | regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947) | 3.32581527 |
| 102 | wound healing, spreading of epidermal cells (GO:0035313) | 3.32578353 |
| 103 | positive regulation of coagulation (GO:0050820) | 3.31392275 |
| 104 | positive regulation of odontogenesis (GO:0042482) | 3.30110293 |
| 105 | positive regulation of astrocyte differentiation (GO:0048711) | 3.29230457 |
| 106 | negative regulation of coagulation (GO:0050819) | 3.25813588 |
| 107 | bile acid metabolic process (GO:0008206) | 3.25532556 |
| 108 | hyaluronan catabolic process (GO:0030214) | 3.24774529 |
| 109 | negative regulation of vasculature development (GO:1901343) | 3.24754002 |
| 110 | positive regulation of receptor recycling (GO:0001921) | 3.24533114 |
| 111 | substrate-dependent cell migration (GO:0006929) | 3.23924966 |
| 112 | endothelial cell differentiation (GO:0045446) | 3.22467497 |
| 113 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.20889593 |
| 114 | endocrine hormone secretion (GO:0060986) | 3.20761803 |
| 115 | protein kinase C signaling (GO:0070528) | 3.20112243 |
| 116 | arginine metabolic process (GO:0006525) | 3.19588949 |
| 117 | positive regulation of urine volume (GO:0035810) | 3.18754141 |
| 118 | cysteine metabolic process (GO:0006534) | 3.16990632 |
| 119 | negative regulation of endothelial cell migration (GO:0010596) | 3.16495786 |
| 120 | regulation of vasculogenesis (GO:2001212) | 3.15930816 |
| 121 | homocysteine metabolic process (GO:0050667) | 3.13552333 |
| 122 | phospholipid efflux (GO:0033700) | 3.13422674 |
| 123 | neuron remodeling (GO:0016322) | 3.13382409 |
| 124 | response to follicle-stimulating hormone (GO:0032354) | 3.12803727 |
| 125 | * blood vessel morphogenesis (GO:0048514) | 3.11118209 |
| 126 | axon extension involved in axon guidance (GO:0048846) | 3.10802399 |
| 127 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.10802399 |
| 128 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.10648166 |
| 129 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.10648166 |
| 130 | negative regulation of lipase activity (GO:0060192) | 3.08707018 |
| 131 | regulation of cholesterol esterification (GO:0010872) | 3.08059086 |
| 132 | atrioventricular valve morphogenesis (GO:0003181) | 3.07695024 |
| 133 | sterol catabolic process (GO:0016127) | 3.07656633 |
| 134 | cholesterol catabolic process (GO:0006707) | 3.07656633 |
| 135 | amino-acid betaine metabolic process (GO:0006577) | 3.07103788 |
| 136 | negative regulation of platelet activation (GO:0010544) | 3.06947018 |
| 137 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 3.06820661 |
| 138 | * angiogenesis (GO:0001525) | 3.06595482 |
| 139 | nitrogen cycle metabolic process (GO:0071941) | 3.05785354 |
| 140 | endothelial cell morphogenesis (GO:0001886) | 3.04757797 |
| 141 | negative regulation of wound healing (GO:0061045) | 3.04376668 |
| 142 | apoptotic process involved in morphogenesis (GO:0060561) | 3.03756181 |
| 143 | heart trabecula formation (GO:0060347) | 3.03449512 |
| 144 | serine family amino acid catabolic process (GO:0009071) | 3.02737036 |
| 145 | endothelial cell chemotaxis (GO:0035767) | 3.02102200 |
| 146 | glucocorticoid biosynthetic process (GO:0006704) | 3.01272724 |
| 147 | cholesterol homeostasis (GO:0042632) | 3.00875736 |
| 148 | blood vessel maturation (GO:0001955) | 3.00469093 |
| 149 | tyrosine metabolic process (GO:0006570) | 2.98675449 |
| 150 | bile acid and bile salt transport (GO:0015721) | 2.98482383 |
| 151 | regulation of cardioblast differentiation (GO:0051890) | 2.98145859 |
| 152 | lipoprotein metabolic process (GO:0042157) | 2.97454055 |
| 153 | sterol homeostasis (GO:0055092) | 2.97025511 |
| 154 | alpha-amino acid catabolic process (GO:1901606) | 2.95563448 |
| 155 | endothelial cell migration (GO:0043542) | 2.92918851 |
| 156 | endothelial cell proliferation (GO:0001935) | 2.91894684 |
| 157 | regulation of glomerular filtration (GO:0003093) | 2.90485060 |
| 158 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.90210288 |
| 159 | adherens junction assembly (GO:0034333) | 2.89792620 |
| 160 | cell migration involved in heart development (GO:0060973) | 2.84767847 |
| 161 | negative regulation of adherens junction organization (GO:1903392) | 2.81708817 |
| 162 | negative regulation of focal adhesion assembly (GO:0051895) | 2.81708817 |
| 163 | negative regulation of cell junction assembly (GO:1901889) | 2.81708817 |
| 164 | cell surface receptor signaling pathway involved in heart development (GO:0061311) | 2.81462822 |
| 165 | venous blood vessel morphogenesis (GO:0048845) | 2.79897052 |
| 166 | * positive regulation of endothelial cell migration (GO:0010595) | 2.79870527 |
| 167 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.77065787 |
| 168 | glomerular basement membrane development (GO:0032836) | 2.70873543 |
| 169 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.70150727 |
| 170 | ovulation from ovarian follicle (GO:0001542) | 2.67871794 |
| 171 | * regulation of epithelial cell migration (GO:0010632) | 2.67469275 |
| 172 | positive regulation of glomerulus development (GO:0090193) | 2.66082492 |
| 173 | female pregnancy (GO:0007565) | 2.65829796 |
| 174 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.65341267 |
| 175 | cardiac muscle tissue development (GO:0048738) | 2.61977993 |
| 176 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.61025398 |
| 177 | artery morphogenesis (GO:0048844) | 2.60463160 |
| 178 | establishment of endothelial barrier (GO:0061028) | 2.60329028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.81961954 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.44967947 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.44904814 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.39614952 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.72475342 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.60768043 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.99368684 |
| 8 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.40767403 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.34965867 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.34107971 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.93673787 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.93159861 |
| 13 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.58169354 |
| 14 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.57293609 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.44936459 |
| 16 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.41922083 |
| 17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.36970970 |
| 18 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.36480931 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17228306 |
| 20 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12796669 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12796669 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.10900447 |
| 23 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08526928 |
| 24 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.08014308 |
| 25 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.08014308 |
| 26 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.08014308 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.93819733 |
| 28 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.89780758 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.87024236 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.80417603 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.79406115 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76745272 |
| 33 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.75862107 |
| 34 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.75386755 |
| 35 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.72374479 |
| 36 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71447003 |
| 37 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.69732556 |
| 38 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.68798908 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.63512194 |
| 40 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.61181928 |
| 41 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.61144690 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.60487790 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.56924034 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56731097 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56677698 |
| 46 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.54316113 |
| 47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.54269747 |
| 48 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.47305937 |
| 49 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.46849309 |
| 50 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.45522716 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.42791192 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.42664553 |
| 53 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42292159 |
| 54 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.40916063 |
| 55 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.39886647 |
| 56 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.39368441 |
| 57 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.39137422 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.38520289 |
| 59 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.37656717 |
| 60 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.36669841 |
| 61 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.36669841 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.36440786 |
| 63 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.35600730 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.34998566 |
| 65 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.34315399 |
| 66 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.34071862 |
| 67 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.33046071 |
| 68 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.30178683 |
| 69 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.29298185 |
| 70 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.28967965 |
| 71 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.28131164 |
| 72 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.27386180 |
| 73 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.25359119 |
| 74 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.24630901 |
| 75 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.24019934 |
| 76 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.23774232 |
| 77 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.23492692 |
| 78 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23024890 |
| 79 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22619660 |
| 80 | GATA1_22025678_ChIP-Seq_K562_Human | 1.21379929 |
| 81 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.21149477 |
| 82 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19869842 |
| 83 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.16696455 |
| 84 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.16596863 |
| 85 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16158957 |
| 86 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14844763 |
| 87 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12075628 |
| 88 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.11542372 |
| 89 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.11371028 |
| 90 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.10598202 |
| 91 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.10472834 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.10384344 |
| 93 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.09922238 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09276333 |
| 95 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.08785709 |
| 96 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08579529 |
| 97 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.06537133 |
| 98 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.06136854 |
| 99 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.05702306 |
| 100 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.05139680 |
| 101 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04683892 |
| 102 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.04084541 |
| 103 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03640601 |
| 104 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.03610290 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.03177321 |
| 106 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.02522031 |
| 107 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.02421457 |
| 108 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.02267518 |
| 109 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.02220780 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01753622 |
| 111 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.01675778 |
| 112 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.01435226 |
| 113 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.01227716 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00954477 |
| 115 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98460747 |
| 116 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98348330 |
| 117 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98105790 |
| 118 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.97924398 |
| 119 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.97332483 |
| 120 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.97267490 |
| 121 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92611117 |
| 122 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91425879 |
| 123 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90141377 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87968907 |
| 125 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87796139 |
| 126 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87796139 |
| 127 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87683825 |
| 128 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.85553853 |
| 129 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.84899577 |
| 130 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.82878132 |
| 131 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.81438840 |
| 132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80885694 |
| 133 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80121401 |
| 134 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.80085319 |
| 135 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.79477449 |
| 136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.78428544 |
| 137 | * ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78303944 |
| 138 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.77914650 |
| 139 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.77316742 |
| 140 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.77020791 |
| 141 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76916089 |
| 142 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75035945 |
| 143 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.73251021 |
| 144 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.73251021 |
| 145 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67299577 |
| 146 | ATF3_27146783_Chip-Seq_COLON_Human | 0.67060586 |
| 147 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.65619129 |
| 148 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.65463770 |
| 149 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.64900270 |
| 150 | KDM2B_26808549_Chip-Seq_K562_Human | 0.63220320 |
| 151 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.63176979 |
| 152 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62278596 |
| 153 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.62040761 |
| 154 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.62036408 |
| 155 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.61680913 |
| 156 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.60818825 |
| 157 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.60760743 |
| 158 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.60263997 |
| 159 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.59265499 |
| 160 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.58956059 |
| 161 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.58704578 |
| 162 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.58417599 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006054_spinal_hemorrhage | 5.59856424 |
| 2 | * MP0010368_abnormal_lymphatic_system | 5.24123830 |
| 3 | * MP0001879_abnormal_lymphatic_vessel | 4.77148366 |
| 4 | MP0003724_increased_susceptibility_to | 4.36800433 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 4.21619112 |
| 6 | MP0005360_urolithiasis | 4.09812942 |
| 7 | MP0005085_abnormal_gallbladder_physiolo | 3.56811992 |
| 8 | MP0005365_abnormal_bile_salt | 3.38554577 |
| 9 | MP0004272_abnormal_basement_membrane | 3.30506003 |
| 10 | MP0008004_abnormal_stomach_pH | 3.21055651 |
| 11 | MP0005167_abnormal_blood-brain_barrier | 2.94503149 |
| 12 | MP0003300_gastrointestinal_ulcer | 2.69419377 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.67161181 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.34801013 |
| 15 | MP0003252_abnormal_bile_duct | 2.30458907 |
| 16 | MP0004215_abnormal_myocardial_fiber | 2.12071440 |
| 17 | MP0004782_abnormal_surfactant_physiolog | 2.04423576 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 1.84394302 |
| 19 | MP0000751_myopathy | 1.83285023 |
| 20 | MP0004084_abnormal_cardiac_muscle | 1.80697129 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 1.77147082 |
| 22 | MP0005083_abnormal_biliary_tract | 1.75822930 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.75590117 |
| 24 | MP0001851_eye_inflammation | 1.74960760 |
| 25 | MP0002249_abnormal_larynx_morphology | 1.73303512 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 1.71518004 |
| 27 | MP0010030_abnormal_orbit_morphology | 1.67109120 |
| 28 | MP0004130_abnormal_muscle_cell | 1.65514699 |
| 29 | MP0009840_abnormal_foam_cell | 1.63548304 |
| 30 | MP0002933_joint_inflammation | 1.59429077 |
| 31 | MP0003828_pulmonary_edema | 1.57374290 |
| 32 | MP0005670_abnormal_white_adipose | 1.54162391 |
| 33 | MP0000609_abnormal_liver_physiology | 1.52164245 |
| 34 | MP0000678_abnormal_parathyroid_gland | 1.50596158 |
| 35 | MP0001849_ear_inflammation | 1.45513851 |
| 36 | MP0000767_abnormal_smooth_muscle | 1.41372554 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.38586099 |
| 38 | MP0001915_intracranial_hemorrhage | 1.36347634 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.34352514 |
| 40 | * MP0000003_abnormal_adipose_tissue | 1.33971061 |
| 41 | MP0004484_altered_response_of | 1.33079829 |
| 42 | MP0000465_gastrointestinal_hemorrhage | 1.31690218 |
| 43 | MP0005332_abnormal_amino_acid | 1.31069976 |
| 44 | MP0000537_abnormal_urethra_morphology | 1.30694976 |
| 45 | MP0000249_abnormal_blood_vessel | 1.21414434 |
| 46 | MP0003279_aneurysm | 1.20049913 |
| 47 | MP0004019_abnormal_vitamin_homeostasis | 1.19957345 |
| 48 | MP0006138_congestive_heart_failure | 1.19545686 |
| 49 | MP0000049_abnormal_middle_ear | 1.18756493 |
| 50 | MP0009697_abnormal_copulation | 1.18079617 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.17921314 |
| 52 | MP0001666_abnormal_nutrient_absorption | 1.17401628 |
| 53 | MP0005409_darkened_coat_color | 1.17168790 |
| 54 | MP0002118_abnormal_lipid_homeostasis | 1.17104060 |
| 55 | MP0005595_abnormal_vascular_smooth | 1.14104226 |
| 56 | * MP0005375_adipose_tissue_phenotype | 1.14085512 |
| 57 | MP0005165_increased_susceptibility_to | 1.08964435 |
| 58 | * MP0002128_abnormal_blood_circulation | 1.08940258 |
| 59 | MP0004145_abnormal_muscle_electrophysio | 1.06093705 |
| 60 | MP0004036_abnormal_muscle_relaxation | 1.03298205 |
| 61 | MP0002837_dystrophic_cardiac_calcinosis | 1.00294210 |
| 62 | MP0002332_abnormal_exercise_endurance | 1.00276212 |
| 63 | MP0002932_abnormal_joint_morphology | 1.00255155 |
| 64 | MP0009763_increased_sensitivity_to | 1.00246589 |
| 65 | MP0005385_cardiovascular_system_phenoty | 0.99792199 |
| 66 | MP0001544_abnormal_cardiovascular_syste | 0.99792199 |
| 67 | MP0002108_abnormal_muscle_morphology | 0.99307429 |
| 68 | MP0000343_altered_response_to | 0.98846700 |
| 69 | MP0002295_abnormal_pulmonary_circulatio | 0.97791809 |
| 70 | MP0005164_abnormal_response_to | 0.97789400 |
| 71 | MP0003303_peritoneal_inflammation | 0.97499882 |
| 72 | MP0006276_abnormal_autonomic_nervous | 0.97388198 |
| 73 | MP0010630_abnormal_cardiac_muscle | 0.96756862 |
| 74 | * MP0000598_abnormal_liver_morphology | 0.96744177 |
| 75 | MP0002127_abnormal_cardiovascular_syste | 0.95008920 |
| 76 | MP0009764_decreased_sensitivity_to | 0.93988638 |
| 77 | MP0002697_abnormal_eye_size | 0.90457150 |
| 78 | MP0005330_cardiomyopathy | 0.90046003 |
| 79 | * MP0003984_embryonic_growth_retardation | 0.89776921 |
| 80 | MP0000681_abnormal_thyroid_gland | 0.89633993 |
| 81 | * MP0001614_abnormal_blood_vessel | 0.89352885 |
| 82 | MP0004147_increased_porphyrin_level | 0.88641487 |
| 83 | * MP0002086_abnormal_extraembryonic_tissu | 0.87905568 |
| 84 | MP0000733_abnormal_muscle_development | 0.87877024 |
| 85 | MP0008775_abnormal_heart_ventricle | 0.86489666 |
| 86 | MP0004085_abnormal_heartbeat | 0.86400391 |
| 87 | * MP0001784_abnormal_fluid_regulation | 0.85813663 |
| 88 | * MP0002925_abnormal_cardiovascular_devel | 0.85775024 |
| 89 | * MP0002088_abnormal_embryonic_growth/wei | 0.85080970 |
| 90 | MP0002254_reproductive_system_inflammat | 0.83837258 |
| 91 | MP0002092_abnormal_eye_morphology | 0.82104872 |
| 92 | MP0003935_abnormal_craniofacial_develop | 0.80857607 |
| 93 | MP0003045_fibrosis | 0.80854561 |
| 94 | MP0003948_abnormal_gas_homeostasis | 0.77030249 |
| 95 | MP0003195_calcinosis | 0.77014708 |
| 96 | MP0009643_abnormal_urine_homeostasis | 0.76754594 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76346879 |
| 98 | MP0000230_abnormal_systemic_arterial | 0.75277294 |
| 99 | MP0004883_abnormal_blood_vessel | 0.74019296 |
| 100 | MP0001873_stomach_inflammation | 0.73113355 |
| 101 | MP0002972_abnormal_cardiac_muscle | 0.72449936 |
| 102 | MP0005666_abnormal_adipose_tissue | 0.72222976 |
| 103 | MP0003943_abnormal_hepatobiliary_system | 0.70931274 |
| 104 | MP0001661_extended_life_span | 0.69419081 |
| 105 | MP0005647_abnormal_sex_gland | 0.69128466 |
| 106 | MP0000759_abnormal_skeletal_muscle | 0.69100802 |
| 107 | * MP0000266_abnormal_heart_morphology | 0.68843461 |
| 108 | MP0004233_abnormal_muscle_weight | 0.68663602 |
| 109 | MP0009053_abnormal_anal_canal | 0.68547503 |
| 110 | * MP0005380_embryogenesis_phenotype | 0.67835306 |
| 111 | * MP0001672_abnormal_embryogenesis/_devel | 0.67835306 |
| 112 | MP0003868_abnormal_feces_composition | 0.65982921 |
| 113 | MP0005023_abnormal_wound_healing | 0.64900621 |
| 114 | MP0002106_abnormal_muscle_physiology | 0.64182478 |
| 115 | MP0008469_abnormal_protein_level | 0.63805972 |
| 116 | MP0005623_abnormal_meninges_morphology | 0.63686114 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.63434602 |
| 118 | MP0000467_abnormal_esophagus_morphology | 0.62063696 |
| 119 | MP0001730_embryonic_growth_arrest | 0.62032882 |
| 120 | MP0005620_abnormal_muscle_contractility | 0.61298322 |
| 121 | MP0001533_abnormal_skeleton_physiology | 0.61073090 |
| 122 | MP0005503_abnormal_tendon_morphology | 0.59897826 |
| 123 | MP0005369_muscle_phenotype | 0.58590896 |
| 124 | MP0003385_abnormal_body_wall | 0.58357410 |
| 125 | MP0003091_abnormal_cell_migration | 0.58269603 |
| 126 | MP0003119_abnormal_digestive_system | 0.56788305 |
| 127 | MP0000462_abnormal_digestive_system | 0.55036542 |
| 128 | MP0005084_abnormal_gallbladder_morpholo | 0.54400792 |
| 129 | MP0005187_abnormal_penis_morphology | 0.53676995 |
| 130 | * MP0000013_abnormal_adipose_tissue | 0.53345873 |
| 131 | MP0004087_abnormal_muscle_fiber | 0.53183147 |
| 132 | MP0008874_decreased_physiological_sensi | 0.53118421 |
| 133 | MP0004858_abnormal_nervous_system | 0.52944618 |
| 134 | MP0004185_abnormal_adipocyte_glucose | 0.52901133 |
| 135 | MP0001293_anophthalmia | 0.52871567 |
| 136 | MP0005636_abnormal_mineral_homeostasis | 0.52042505 |
| 137 | MP0009765_abnormal_xenobiotic_induced | 0.51999138 |
| 138 | MP0002133_abnormal_respiratory_system | 0.51776932 |
| 139 | MP0005388_respiratory_system_phenotype | 0.51776932 |
| 140 | MP0002084_abnormal_developmental_patter | 0.51611922 |
| 141 | MP0002896_abnormal_bone_mineralization | 0.51290902 |
| 142 | MP0003186_abnormal_redox_activity | 0.51234691 |
| 143 | MP0005275_abnormal_skin_tensile | 0.50951971 |
| 144 | MP0002234_abnormal_pharynx_morphology | 0.50776800 |
| 145 | MP0009115_abnormal_fat_cell | 0.50659870 |
| 146 | MP0002796_impaired_skin_barrier | 0.49804974 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.30585214 |
| 2 | Skull defect (HP:0001362) | 5.11986234 |
| 3 | Prolonged partial thromboplastin time (HP:0003645) | 5.10485542 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.88057443 |
| 5 | Joint hemorrhage (HP:0005261) | 4.51591445 |
| 6 | Polycythemia (HP:0001901) | 4.31726124 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.29394245 |
| 8 | Broad metatarsal (HP:0001783) | 4.29247183 |
| 9 | Esophageal varix (HP:0002040) | 4.26339231 |
| 10 | Lymphangioma (HP:0100764) | 4.21800472 |
| 11 | Xanthomatosis (HP:0000991) | 4.21069063 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.19233531 |
| 13 | * Nonimmune hydrops fetalis (HP:0001790) | 4.12781787 |
| 14 | Hypoalphalipoproteinemia (HP:0003233) | 4.09055318 |
| 15 | Short hallux (HP:0010109) | 3.88264847 |
| 16 | Wrist flexion contracture (HP:0001239) | 3.83127495 |
| 17 | Abnormality of the intrinsic pathway (HP:0010989) | 3.82602867 |
| 18 | Hypolipoproteinemia (HP:0010981) | 3.68861399 |
| 19 | Hypobetalipoproteinemia (HP:0003563) | 3.66855518 |
| 20 | Hyperlipoproteinemia (HP:0010980) | 3.65479608 |
| 21 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 3.60349957 |
| 22 | Increased variability in muscle fiber diameter (HP:0003557) | 3.57490322 |
| 23 | Spontaneous hematomas (HP:0007420) | 3.51693435 |
| 24 | Ventricular tachycardia (HP:0004756) | 3.42042232 |
| 25 | Adactyly (HP:0009776) | 3.40764058 |
| 26 | Complement deficiency (HP:0004431) | 3.37432648 |
| 27 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.33505961 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.32396915 |
| 29 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.22512617 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.18658874 |
| 31 | Vascular calcification (HP:0004934) | 3.15717211 |
| 32 | Porencephaly (HP:0002132) | 3.14125438 |
| 33 | Hematochezia (HP:0002573) | 3.13117124 |
| 34 | Cardiovascular calcification (HP:0011915) | 3.12001467 |
| 35 | Spinal rigidity (HP:0003306) | 3.11322696 |
| 36 | Hyperammonemia (HP:0001987) | 3.09978332 |
| 37 | Hypoplastic ischia (HP:0003175) | 3.08582959 |
| 38 | Absent hand (HP:0004050) | 3.03984053 |
| 39 | Abnormality of the hepatic vasculature (HP:0006707) | 2.99777582 |
| 40 | Hypoplasia of the iris (HP:0007676) | 2.99372215 |
| 41 | Abnormality of the ischium (HP:0003174) | 2.94801371 |
| 42 | Conjunctival telangiectasia (HP:0000524) | 2.90691498 |
| 43 | Ketosis (HP:0001946) | 2.88199397 |
| 44 | Cerebral hemorrhage (HP:0001342) | 2.86241116 |
| 45 | Hemorrhage of the eye (HP:0011885) | 2.85433688 |
| 46 | Difficulty climbing stairs (HP:0003551) | 2.85260332 |
| 47 | High pitched voice (HP:0001620) | 2.79129113 |
| 48 | Congenital, generalized hypertrichosis (HP:0004540) | 2.73549032 |
| 49 | Myotonia (HP:0002486) | 2.69756326 |
| 50 | Difficulty running (HP:0009046) | 2.63224206 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.61421808 |
| 52 | Epidermoid cyst (HP:0200040) | 2.59183537 |
| 53 | Absent eyelashes (HP:0000561) | 2.58952510 |
| 54 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56093990 |
| 55 | Aortic aneurysm (HP:0004942) | 2.55833103 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.55312465 |
| 57 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.53587911 |
| 58 | Cardiomegaly (HP:0001640) | 2.52957532 |
| 59 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.52629090 |
| 60 | Fat malabsorption (HP:0002630) | 2.51259367 |
| 61 | Myocardial infarction (HP:0001658) | 2.47697736 |
| 62 | Short 4th metacarpal (HP:0010044) | 2.46981277 |
| 63 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.46981277 |
| 64 | Ectopia lentis (HP:0001083) | 2.44483673 |
| 65 | Abnormality of complement system (HP:0005339) | 2.43742054 |
| 66 | Abnormality of the 4th metacarpal (HP:0010012) | 2.43194531 |
| 67 | Shallow orbits (HP:0000586) | 2.42991588 |
| 68 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.42420654 |
| 69 | Right ventricular cardiomyopathy (HP:0011663) | 2.41587581 |
| 70 | Thrombophlebitis (HP:0004418) | 2.40229313 |
| 71 | Protrusio acetabuli (HP:0003179) | 2.39055790 |
| 72 | Abnormality of the nasal mucosa (HP:0000433) | 2.38124799 |
| 73 | Disproportionate tall stature (HP:0001519) | 2.37871238 |
| 74 | Ketoacidosis (HP:0001993) | 2.35616400 |
| 75 | Pulmonary hypertension (HP:0002092) | 2.33154976 |
| 76 | Hypercholesterolemia (HP:0003124) | 2.33026335 |
| 77 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.32692096 |
| 78 | Hyperglycinemia (HP:0002154) | 2.31866975 |
| 79 | Premature rupture of membranes (HP:0001788) | 2.30580237 |
| 80 | Abnormality of the peritoneum (HP:0002585) | 2.30214132 |
| 81 | Distal lower limb amyotrophy (HP:0008944) | 2.29831300 |
| 82 | Overgrowth (HP:0001548) | 2.29009196 |
| 83 | Venous insufficiency (HP:0005293) | 2.28354906 |
| 84 | Prominent supraorbital ridges (HP:0000336) | 2.28223073 |
| 85 | Visceral angiomatosis (HP:0100761) | 2.26645934 |
| 86 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.26550897 |
| 87 | Hyperglycinuria (HP:0003108) | 2.24566815 |
| 88 | Hip contracture (HP:0003273) | 2.23406167 |
| 89 | Stroke (HP:0001297) | 2.23004042 |
| 90 | Increased connective tissue (HP:0009025) | 2.22972352 |
| 91 | Long eyelashes (HP:0000527) | 2.22895263 |
| 92 | Large for gestational age (HP:0001520) | 2.22505887 |
| 93 | Abnormality of glycine metabolism (HP:0010895) | 2.21382162 |
| 94 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.21382162 |
| 95 | Abnormality of the aortic arch (HP:0012303) | 2.21207191 |
| 96 | Vitreoretinal degeneration (HP:0000655) | 2.19597298 |
| 97 | Abnormality of the anterior chamber (HP:0000593) | 2.19500418 |
| 98 | Tetraparesis (HP:0002273) | 2.18718580 |
| 99 | Absent toe (HP:0010760) | 2.17828615 |
| 100 | Hyporeflexia of lower limbs (HP:0002600) | 2.17633901 |
| 101 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.16695763 |
| 102 | Venous abnormality (HP:0002624) | 2.16596269 |
| 103 | Skin nodule (HP:0200036) | 2.16484749 |
| 104 | Aneurysm (HP:0002617) | 2.15639002 |
| 105 | Hemangiomatosis (HP:0007461) | 2.15336902 |
| 106 | * Capillary hemangiomas (HP:0005306) | 2.15011129 |
| 107 | Abnormal vertebral ossification (HP:0100569) | 2.13186966 |
| 108 | Occipital encephalocele (HP:0002085) | 2.12827641 |
| 109 | Hypoglycemic seizures (HP:0002173) | 2.12454446 |
| 110 | Preaxial foot polydactyly (HP:0001841) | 2.11975738 |
| 111 | Mitral stenosis (HP:0001718) | 2.11975347 |
| 112 | Pulmonary embolism (HP:0002204) | 2.11689169 |
| 113 | Mitral valve prolapse (HP:0001634) | 2.09987410 |
| 114 | Abnormality of methionine metabolism (HP:0010901) | 2.09236596 |
| 115 | Pulmonary artery stenosis (HP:0004415) | 2.09050566 |
| 116 | Abnormality of purine metabolism (HP:0004352) | 2.08876749 |
| 117 | Portal hypertension (HP:0001409) | 2.08308911 |
| 118 | Delayed CNS myelination (HP:0002188) | 2.07239843 |
| 119 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.07172886 |
| 120 | Abnormality of the fingertips (HP:0001211) | 2.04492772 |
| 121 | Muscle fiber splitting (HP:0003555) | 2.03787320 |
| 122 | Hyperbilirubinemia (HP:0002904) | 2.03000985 |
| 123 | Absent eyebrow (HP:0002223) | 2.02444558 |
| 124 | Exotropia (HP:0000577) | 2.02345135 |
| 125 | Interstitial pulmonary disease (HP:0006530) | 2.01972950 |
| 126 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.00338165 |
| 127 | Dicarboxylic aciduria (HP:0003215) | 2.00338165 |
| 128 | Neonatal death (HP:0003811) | 1.99474556 |
| 129 | Amyloidosis (HP:0011034) | 1.99382209 |
| 130 | Spastic diplegia (HP:0001264) | 1.98976059 |
| 131 | Hyperglycemia (HP:0003074) | 1.98436360 |
| 132 | Atrioventricular block (HP:0001678) | 1.98291700 |
| 133 | Hemiplegia (HP:0002301) | 1.97947986 |
| 134 | Abnormality of nucleobase metabolism (HP:0010932) | 1.96156898 |
| 135 | Thin ribs (HP:0000883) | 1.96147253 |
| 136 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96097632 |
| 137 | Neoplasm of the heart (HP:0100544) | 1.94570706 |
| 138 | Areflexia of lower limbs (HP:0002522) | 1.93367565 |
| 139 | Conjugated hyperbilirubinemia (HP:0002908) | 1.93116759 |
| 140 | Stridor (HP:0010307) | 1.90390921 |
| 141 | Cervical subluxation (HP:0003308) | 1.88986820 |
| 142 | Chondrocalcinosis (HP:0000934) | 1.88714792 |
| 143 | Short clavicles (HP:0000894) | 1.87807212 |
| 144 | Spontaneous abortion (HP:0005268) | 1.87236790 |
| 145 | Sudden death (HP:0001699) | 1.87218664 |
| 146 | Anterior segment dysgenesis (HP:0007700) | 1.86453405 |
| 147 | Muscle fibrillation (HP:0010546) | 1.85932044 |
| 148 | Cavernous hemangioma (HP:0001048) | 1.85052394 |
| 149 | Menorrhagia (HP:0000132) | 1.83874077 |
| 150 | Cutis marmorata (HP:0000965) | 1.83749446 |
| 151 | Short palpebral fissure (HP:0012745) | 1.82938078 |
| 152 | Atrial fibrillation (HP:0005110) | 1.82311754 |
| 153 | Limited hip movement (HP:0008800) | 1.78646133 |
| 154 | Joint contractures involving the joints of the feet (HP:0100492) | 1.78260096 |
| 155 | Flexion contracture of toe (HP:0005830) | 1.78260096 |
| 156 | Round ear (HP:0100830) | 1.77190095 |
| 157 | Germ cell neoplasia (HP:0100728) | 1.76995307 |
| 158 | Lumbar hyperlordosis (HP:0002938) | 1.74499761 |
| 159 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.74400234 |
| 160 | Aortic valve stenosis (HP:0001650) | 1.73999130 |
| 161 | J-shaped sella turcica (HP:0002680) | 1.73017865 |
| 162 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.72422035 |
| 163 | Protruding ear (HP:0000411) | 1.70808503 |
| 164 | Heart block (HP:0012722) | 1.69993356 |
| 165 | Asymmetric septal hypertrophy (HP:0001670) | 1.69232164 |
| 166 | Abnormal atrioventricular conduction (HP:0005150) | 1.68735791 |
| 167 | Obstructive sleep apnea (HP:0002870) | 1.68607046 |
| 168 | Rectal prolapse (HP:0002035) | 1.66077023 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 9.82896186 |
| 2 | * KDR | 8.29564353 |
| 3 | TGFBR2 | 3.80809639 |
| 4 | ERN1 | 3.16884583 |
| 5 | TGFBR1 | 2.78410914 |
| 6 | FES | 2.59718946 |
| 7 | EEF2K | 2.19560608 |
| 8 | RIPK1 | 2.19290790 |
| 9 | BCKDK | 1.74818914 |
| 10 | PKN2 | 1.74241855 |
| 11 | FGFR4 | 1.70548892 |
| 12 | PTK6 | 1.64431759 |
| 13 | JAK1 | 1.54693318 |
| 14 | SIK1 | 1.50551580 |
| 15 | PTK2B | 1.50512486 |
| 16 | SMG1 | 1.49802283 |
| 17 | EPHB2 | 1.49328634 |
| 18 | EPHB1 | 1.46274842 |
| 19 | GRK1 | 1.40476323 |
| 20 | FER | 1.28173737 |
| 21 | MARK2 | 1.20818963 |
| 22 | TTN | 1.20532250 |
| 23 | CAMK4 | 1.18086115 |
| 24 | JAK3 | 1.17044221 |
| 25 | TRIB3 | 1.16625384 |
| 26 | INSRR | 1.16573082 |
| 27 | FLT3 | 1.12554599 |
| 28 | PRKD3 | 1.09623780 |
| 29 | MAP2K3 | 1.06256403 |
| 30 | RPS6KA2 | 1.03462113 |
| 31 | JAK2 | 1.03227819 |
| 32 | PTK2 | 1.02981361 |
| 33 | MAPK12 | 0.95661074 |
| 34 | MAP3K6 | 0.94158066 |
| 35 | MAP3K13 | 0.93258050 |
| 36 | MET | 0.91155397 |
| 37 | PDGFRA | 0.90525002 |
| 38 | DAPK2 | 0.88815193 |
| 39 | MYLK | 0.83732814 |
| 40 | MAP3K11 | 0.80931822 |
| 41 | PAK4 | 0.80397008 |
| 42 | TNK2 | 0.80359986 |
| 43 | SCYL2 | 0.78522643 |
| 44 | LATS1 | 0.77307974 |
| 45 | PDK2 | 0.74113920 |
| 46 | PRKG2 | 0.70331483 |
| 47 | EPHA2 | 0.70047436 |
| 48 | RPS6KL1 | 0.68898111 |
| 49 | RPS6KC1 | 0.68898111 |
| 50 | CDK12 | 0.67146060 |
| 51 | RET | 0.65258139 |
| 52 | RPS6KA6 | 0.64531093 |
| 53 | TYRO3 | 0.63322640 |
| 54 | TYK2 | 0.62758167 |
| 55 | MAP2K1 | 0.62139077 |
| 56 | MAP3K3 | 0.62056383 |
| 57 | MAPK15 | 0.61906684 |
| 58 | PRKD2 | 0.58213751 |
| 59 | CDC42BPA | 0.57965410 |
| 60 | MAP3K10 | 0.57216798 |
| 61 | ERBB4 | 0.54985782 |
| 62 | CSK | 0.54902727 |
| 63 | LATS2 | 0.52330922 |
| 64 | TEC | 0.51527377 |
| 65 | MAPK7 | 0.51410584 |
| 66 | HIPK2 | 0.50903872 |
| 67 | PRKD1 | 0.50824167 |
| 68 | IGF1R | 0.49513921 |
| 69 | PRKAA2 | 0.47326398 |
| 70 | CSNK1A1L | 0.47215198 |
| 71 | PRKCH | 0.46503854 |
| 72 | AKT2 | 0.46378477 |
| 73 | LRRK2 | 0.46180044 |
| 74 | CSNK1G1 | 0.45936728 |
| 75 | TBK1 | 0.45522264 |
| 76 | MAP3K1 | 0.45332389 |
| 77 | MAP2K6 | 0.45236993 |
| 78 | GSK3A | 0.45191418 |
| 79 | EGFR | 0.45114902 |
| 80 | CDK9 | 0.45105257 |
| 81 | MAP2K2 | 0.43845990 |
| 82 | NEK9 | 0.43578944 |
| 83 | CSNK1G3 | 0.42719723 |
| 84 | TRPM7 | 0.42634839 |
| 85 | FGFR2 | 0.41843955 |
| 86 | ITK | 0.41592777 |
| 87 | HCK | 0.41360444 |
| 88 | DMPK | 0.41205268 |
| 89 | FGFR3 | 0.41112268 |
| 90 | DAPK3 | 0.40835551 |
| 91 | EPHA3 | 0.40797245 |
| 92 | PKN1 | 0.40482761 |
| 93 | MAP2K4 | 0.38978642 |
| 94 | LMTK2 | 0.37306978 |
| 95 | MUSK | 0.35346355 |
| 96 | AKT3 | 0.35231517 |
| 97 | STK10 | 0.33962870 |
| 98 | MAP3K7 | 0.33847442 |
| 99 | PAK2 | 0.32242622 |
| 100 | PAK3 | 0.30895999 |
| 101 | FGFR1 | 0.27246795 |
| 102 | GRK5 | 0.27135214 |
| 103 | MAPK11 | 0.27082279 |
| 104 | CDK6 | 0.27049637 |
| 105 | CAMK1D | 0.26783490 |
| 106 | ABL2 | 0.26229475 |
| 107 | * SRC | 0.26073670 |
| 108 | MTOR | 0.25622391 |
| 109 | MAP4K1 | 0.23683185 |
| 110 | CDK8 | 0.23485950 |
| 111 | CDK3 | 0.23215327 |
| 112 | MAPK4 | 0.23200038 |
| 113 | OBSCN | 0.22702936 |
| 114 | ILK | 0.22232307 |
| 115 | MST1R | 0.21430719 |
| 116 | RPS6KA5 | 0.20548299 |
| 117 | CAMK1G | 0.20285728 |
| 118 | TESK1 | 0.20157163 |
| 119 | ERBB2 | 0.20134185 |
| 120 | PDGFRB | 0.19930015 |
| 121 | CDK7 | 0.19194281 |
| 122 | PRKAA1 | 0.18949073 |
| 123 | PRPF4B | 0.17629405 |
| 124 | NME1 | 0.17474112 |
| 125 | NTRK1 | 0.17259734 |
| 126 | INSR | 0.16990415 |
| 127 | BLK | 0.16988132 |
| 128 | IRAK3 | 0.16523095 |
| 129 | PDPK1 | 0.16134295 |
| 130 | DYRK1B | 0.15506739 |
| 131 | STK11 | 0.15435301 |
| 132 | PIK3CG | 0.14458378 |
| 133 | TAOK3 | 0.14228848 |
| 134 | BMX | 0.14198524 |
| 135 | PRKACG | 0.12480656 |
| 136 | MAP3K14 | 0.12351787 |
| 137 | ROCK1 | 0.11646440 |
| 138 | PHKG1 | 0.10851087 |
| 139 | PHKG2 | 0.10851087 |
| 140 | MAPK1 | 0.10282297 |
| 141 | ZAP70 | 0.09466714 |
| 142 | PIK3CA | 0.09298983 |
| 143 | ICK | 0.08709690 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.96283247 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.87640806 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.52600425 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44077359 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.23712802 |
| 6 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.86814656 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.60371990 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.42170224 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.39623535 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.28880749 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.24433273 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.19628415 |
| 13 | Bile secretion_Homo sapiens_hsa04976 | 1.92503272 |
| 14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.90147479 |
| 15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89214522 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.87655904 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.85416217 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.83320166 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69917994 |
| 20 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.69705034 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66541784 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.63255579 |
| 23 | Axon guidance_Homo sapiens_hsa04360 | 1.62114980 |
| 24 | ABC transporters_Homo sapiens_hsa02010 | 1.61871276 |
| 25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.60306391 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.55218017 |
| 27 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.53664726 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.50346325 |
| 29 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.48552467 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.46140761 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41351308 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.39319740 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.38998259 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 1.35142038 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.32538920 |
| 36 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.25006919 |
| 37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24888719 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.24410852 |
| 39 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.24284060 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.24280304 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.22948885 |
| 42 | Tight junction_Homo sapiens_hsa04530 | 1.22354052 |
| 43 | Bladder cancer_Homo sapiens_hsa05219 | 1.19282578 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.18961243 |
| 45 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.15557804 |
| 46 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.14960687 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.14779425 |
| 48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.14367822 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.13207690 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.10776096 |
| 51 | * Ras signaling pathway_Homo sapiens_hsa04014 | 1.09526265 |
| 52 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.09454072 |
| 53 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.08753950 |
| 54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.06821129 |
| 55 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.04426897 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04115252 |
| 57 | Pathways in cancer_Homo sapiens_hsa05200 | 1.02525242 |
| 58 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.00512302 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99714290 |
| 60 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.98804048 |
| 61 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.96594294 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.95528517 |
| 63 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.95505644 |
| 64 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.93700991 |
| 65 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.92867626 |
| 66 | Glioma_Homo sapiens_hsa05214 | 0.92694323 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.91453687 |
| 68 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.91399963 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.90653479 |
| 70 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.88487252 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87423242 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83695568 |
| 73 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.82538714 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.82319517 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80919679 |
| 76 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.78540769 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.73288690 |
| 78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.72483484 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.71939488 |
| 80 | Insulin resistance_Homo sapiens_hsa04931 | 0.71157051 |
| 81 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.70458111 |
| 82 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.67668622 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.66652420 |
| 84 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.66651014 |
| 85 | Pertussis_Homo sapiens_hsa05133 | 0.65624857 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64400474 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.63692382 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.61335746 |
| 89 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61333975 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.61203485 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.60610110 |
| 92 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59841489 |
| 93 | Endocytosis_Homo sapiens_hsa04144 | 0.58492306 |
| 94 | * Focal adhesion_Homo sapiens_hsa04510 | 0.58196599 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.58161063 |
| 96 | Gap junction_Homo sapiens_hsa04540 | 0.57745014 |
| 97 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.56918899 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56187177 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55911524 |
| 100 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55573490 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.55571772 |
| 102 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55518101 |
| 103 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.55487436 |
| 104 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.54548563 |
| 105 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54352860 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.53537474 |
| 107 | Base excision repair_Homo sapiens_hsa03410 | 0.53037781 |
| 108 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.50128557 |
| 109 | Melanoma_Homo sapiens_hsa05218 | 0.49316175 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47599751 |
| 111 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46557448 |
| 112 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45012038 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41779623 |
| 114 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.41204960 |
| 115 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.41068554 |
| 116 | Alcoholism_Homo sapiens_hsa05034 | 0.40934470 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.40355436 |
| 118 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.39242908 |
| 119 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.38639914 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38618403 |
| 121 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.37999218 |
| 122 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.37646180 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.37436613 |
| 124 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36876519 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.34497784 |
| 126 | Amoebiasis_Homo sapiens_hsa05146 | 0.33343009 |
| 127 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.33313183 |
| 128 | Prion diseases_Homo sapiens_hsa05020 | 0.32769754 |
| 129 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32555105 |
| 130 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.32050832 |
| 131 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31752528 |
| 132 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31064602 |
| 133 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.29849475 |
| 134 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27029946 |
| 135 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.26416080 |
| 136 | Sulfur relay system_Homo sapiens_hsa04122 | 0.25411452 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24887274 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.22243655 |
| 139 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.22016468 |
| 140 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.20645227 |
| 141 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.20557010 |
| 142 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.20317083 |
| 143 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.19707364 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18349297 |
| 145 | Platelet activation_Homo sapiens_hsa04611 | 0.16209448 |
| 146 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.15945248 |
| 147 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12905461 |
| 148 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.12499636 |
| 149 | Metabolic pathways_Homo sapiens_hsa01100 | 0.12311121 |
| 150 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11017274 |
| 151 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.10782944 |
| 152 | Viral myocarditis_Homo sapiens_hsa05416 | 0.09093209 |

